EquitiesLaunch

Rocket Lab Launches Synspective Satellite; Announces Q4 Financial Results

Rocket Lab Successfully Launches Second Mission for Synspective, Deploys 110th Satellite to Orbit
Image via Rocket Lab

Image via Rocket Lab

Rocket Lab (NASDAQ:RKLB) doesn’t procrastinate on Mondays. The launcher had a busy day. 

In NZ: Rocket Lab launched “The Owl’s Night Continues” from its new Pad B. An Electron successfully deployed a StriX-β satellite for Japanese SAR operator Synspective. To date, Rocket Lab has now deployed 110 satellites. 

In VA: As rumored, Rocket Lab has selected Wallops Island, Virginia, for the site of Neutron’s first launchpad and a 250,000-sq-ft. factory/operations facility for the next-gen rocket. Neutron, as a quick reminder, is an 8-ton reusable rocket under development that could eventually support human spaceflight. 

In NYC: $RKLB announced Q4 and full-year financial results. 2021 revenue grew 77% year-over-year to $62.2M, while Q4 revenue came in at $27.5M, a 420% quarter over quarter increase. 

  • Q4 ’21 Launch Services revenue jumped ~1,120% QoQ. Why the huge increase? Well, the company wasn’t able to launch for months in NZ due to Covid restrictions. Think the team was excited to get back out to the launchpad? 
  • Looking forward…$RKLB guided Q1’ 22 revenue to $42M-$47M.
Related Stories
BusinessEquitiesInternational

MDA Space is Safe From Trump Tariffs, Budget Cuts

MDA Space posted its Q1 2025 financial results yesterday, showing a strong quarter with revenues ($351M CAD/$252.3M), backlog ($4.1B CAD/$2.95B), and net income ($37.2M CAD/$26.7M) all up compared to the same period last year.

EquitiesLaunch

Rocket Lab Wins Point-to-Point Demo Contract for Neutron

Time for a rocket cargo survivability experiment.

Launch

FAA OKs More Starship Launches at Starbase

SpaceX received the environmental all-clear to ramp up Starship launch operations in Boca Chica, according to an FAA report released on Tuesday.

EquitiesPolicySatcom

Iridium Is Fighting Starlink and Trump’s Tariffs

Despite beating market expectations with first quarter revenue growth of 5% year-on-year, Iridium’s stock fell nearly 7% in the face of competition and trade wars.